Back to search results

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer · Triple Negative Breast Cancer (TNBC) · HER2-Negative Breast Carcinoma · Node-positive Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of North Carolina, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Taylor Pierce) · Taylor_Pierce@med.unc.edu · 984-974-0400
    Contact: Principal Investigator (Dana Casey, MD)
Study leads

  • Dana Casey, MD

    Principal Investigator

    UNC Lineberger Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)